MedPath

四川合纵泽辉医药科技有限公司

Ownership
-
Established
2022-07-06
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Desloratadine Oral Solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20244920
Approval Date
Sep 19, 2024
NMPA

沙棘分散片

Approval Number
国药准字Z20090499
Approval Date
Jun 15, 2023
NMPA

葫芦素胶囊

Approval Number
国药准字Z20080211
Approval Date
Mar 9, 2023
NMPA

苦参胶囊

Approval Number
国药准字Z20080376
Approval Date
Dec 26, 2022
NMPA

复方天麻胶囊

Approval Number
国药准字Z20050011
Approval Date
Sep 29, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.